Axogen Inc vs Alibaba Group — how do they compare? Axogen Inc trades at $38.5 (market cap $2.06B), while Alibaba Group trades at $116.9 (market cap $270.95B). The key difference: Alibaba Group is far larger — about 131.5× Axogen Inc's market cap, and Alibaba Group pays a 0.93% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | BABA | |
|---|---|---|
Market Cap | $2.06B | $270.95B |
Sector | Technology | Consumer Cyclical |
52-Week High | $46.19 | $189.34 |
52-Week Low | $11.28 | $94.83 |
Enterprise Value | $1.98B | $265.77B |
Volume | — | 18,069,938 |
Dividend Yield | — | 0.93% |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
Alibaba (BABA) trades at $112.35, up 0.02% on the day, with a bullish technical signal and strong analyst consensus. Recent earnings misses contrast with robust fundamentals: revenue grew to $996.35B in 2025, net income margin expanded to 13.05%, and valuation ratios like P/E of 17.36 appear reasonable. The stock faces headwinds from securities investigations but benefits from AI-driven optimism in cloud growth.
Outlook remains positive given Wall Street's $195 price target and 86% buy ratings, though risks include legal overhangs and earnings volatility. AI and cloud initiatives offer growth catalysts, but investors should monitor regulatory developments and quarterly execution against expectations.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Alibaba Group Holding Limited operates as a holding company. The Company provides internet infrastructure, electronic commerce, online financial, and internet content services through its subsidiaries. Alibaba Group Holding offers its products and services worldwide.
Read more on BABA →